Back

A direct factor Xa inhibitor, rivaroxaban, attenuates cardiac hypertrophy and fibrosis in renin-overexpressing hypertensive mice

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Molecular mechanisms of cardiac disease Cardiac Hypertrophy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Masato Narita

Hirosaki University Graduate School of Medicine, Hirosaki (Japan)

9 More presentations in this session

Presentation thumbnail
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
Doctor F. Berisha (Hamburg, DE)
Abstract
Presentation thumbnail
Professor A. Pereira (Funchal, PT)
Abstract
Presentation thumbnail
Doctor E. Daskalopoulos (Brussels, BE)
Abstract
Presentation thumbnail
Professor D. Pascual Figal (Murcia, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Molecular mechanisms of cardiac disease

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Webinar
Elevating cardiac expertise: practical approach to left ventricular hypertrophy phenotypes assessment
thumbnail
Congress Session
Cardiac MRI and the evaluation of hypertrophy: modern insights
thumbnail
Congress Presentation
Left ventricular hypertrophy and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources